Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40233
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDagorn, Pascale Gluais-
dc.contributor.authorBuchholz, Bjoern-
dc.contributor.authorKraus, Andre-
dc.contributor.authorBatchuluun, Battsetseg-
dc.contributor.authorBange, Hester-
dc.contributor.authorBLOCKKEN, Laura-
dc.contributor.authorSteinberg, Gregory R.-
dc.contributor.authorMoller, David E.-
dc.contributor.authorHallakou-Bozec, Sophie-
dc.date.accessioned2023-06-01T08:41:42Z-
dc.date.available2023-06-01T08:41:42Z-
dc.date.issued2023-
dc.date.submitted2023-05-31T11:40:57Z-
dc.identifier.citationKIDNEY INTERNATIONAL, 103 (5) , p. 917 -929-
dc.identifier.urihttp://hdl.handle.net/1942/40233-
dc.description.abstractA novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease-
dc.description.sponsorshipStudies were funded by Poxel SA. BBu was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 387509280, SFB 1350.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.rights2023, International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).-
dc.subject.otherADPKD-
dc.subject.otherAMPK-
dc.subject.otherPXL770-
dc.subject.otherfibrosis-
dc.subject.otherinflammation-
dc.subject.othermitochondria-
dc.subject.otherMice-
dc.subject.otherAnimals-
dc.subject.otherDogs-
dc.subject.otherAdenosine Monophosphate-
dc.subject.otherAMP-Activated Protein Kinases-
dc.subject.otherKidney-
dc.subject.otherMice, Knockout-
dc.subject.otherDisease Progression-
dc.subject.otherTRPP Cation Channels-
dc.subject.otherPolycystic Kidney, Autosomal Dominant-
dc.subject.otherRenal Insufficiency-
dc.subject.otherCysts-
dc.titleA novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease-
dc.typeJournal Contribution-
dc.identifier.epage929-
dc.identifier.issue5-
dc.identifier.spage917-
dc.identifier.volume103-
local.format.pages13-
local.bibliographicCitation.jcatA1-
dc.description.notesHallakou-Bozec, S (corresponding author), Poxel SA, 259 Av Jean Jaures, F-69007 Lyon, France.-
dc.description.notessophie.bozec@poxelpharma.com-
local.publisher.placeSTE 800, 230 PARK AVE, NEW YORK, NY 10169 USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
local.classdsPublValOverrule/no_publishing_delay-
dc.identifier.doi10.1016/j.kint.2023.01.026-
dc.identifier.pmid36804411-
dc.identifier.isi000984794600001-
dc.contributor.orcidgluais-dagorn, pascale/0000-0002-5409-3236-
local.provider.typewosris-
local.description.affiliation[Dagorn, Pascale Gluais; Moller, David E.; Hallakou-Bozec, Sophie] Poxel SA, 259 Av Jean Jaures, F-69007 Lyon, France.-
local.description.affiliation[Buchholz, Bjoern; Kraus, Andre] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany.-
local.description.affiliation[Batchuluun, Battsetseg; Steinberg, Gregory R.] McMaster Univ, Ctr Metab Obes & Diabet Res, Dept Med & Biochem & Biomed Sci, Hamilton, ON, Canada.-
local.description.affiliation[Bange, Hester] Crown Bosci Netherlands BV, Leiden, Netherlands.-
local.description.affiliation[Blockken, Laura] InnoSer Belgie NV, Diepenbeek, Belgium.-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.contributorDagorn, Pascale Gluais-
item.contributorBuchholz, Bjoern-
item.contributorKraus, Andre-
item.contributorBatchuluun, Battsetseg-
item.contributorBange, Hester-
item.contributorBLOCKKEN, Laura-
item.contributorSteinberg, Gregory R.-
item.contributorMoller, David E.-
item.contributorHallakou-Bozec, Sophie-
item.fullcitationDagorn, Pascale Gluais; Buchholz, Bjoern; Kraus, Andre; Batchuluun, Battsetseg; Bange, Hester; BLOCKKEN, Laura; Steinberg, Gregory R.; Moller, David E. & Hallakou-Bozec, Sophie (2023) A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease. In: KIDNEY INTERNATIONAL, 103 (5) , p. 917 -929.-
item.accessRightsOpen Access-
crisitem.journal.issn0085-2538-
crisitem.journal.eissn1523-1755-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease.pdfPublished version2.65 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

17
checked on Jan 24, 2026

WEB OF SCIENCETM
Citations

18
checked on Jan 21, 2026

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.